Keith Padbury’s experience of the PCA3 test, a new genetics based assessment of prostate cancer risk

Keith Padbury was one of the first patients to have a PCA3 test, a new genetics based assessment of prostate cancer risk five years ago. He has benefitted from advanced assessments which mean unnecessary biopsies are avoided. Keith describes his own experience and how an elevated PSA result does not inevitably lead to a biopsy and further interventions.
“I was in my early fifties and began to need the toilet more often and have some difficulty in passing water. Through my employment as an engineer, I have regular company medicals and those include a PSA test. My reading was slightly above 3 and so my GP advised me to see a specialist, although he felt there was nothing to worry about. Through my employers, I had private medical insurance and a friend of my partner who works in the medical profession advised me to see Mr Doherty, as he has a very good reputation.
I knew what a prostate biopsy involved and I didn’t want to have one unless there was a real need to do so. When I first saw Mr Doherty, he suggested I have a test called a PCA3, which is a genetics based assessment and provides a different sort of reading to the PSA. It came back negative. Mr Doherty decided on the basis of these two specialist assessments, I didn’t need a biopsy.
I also had an ultrasound scan of my prostate which showed it was enlarged and was prescribed alpha blockers which help to relax the muscles around the bladder and prostate so it is easier to go to the toilet. That has been a big help with the problem of needing to go to the toilet a lot.
My first appointment with Mr Doherty was five years ago. Since then, I’ve come into BPC for assessment every six months and now, I come in annually. As well as having a PCA3 test, I’ve also had an enhanced prostate MRI scan and I have still avoided having a biopsy. Of course, I’m prepared to have one if necessary but I don’t think it should automatically be the first step after a slightly raised PSA result.
I do feel a little anxious every time I have to come into the clinic, but I feel completely confident in Mr Doherty, knowing the plan is being managed by one of the country’s leading experts in his field. I know my PSA is being monitored and we have a map of my readings showing the pattern over many years. I’m in the right hands and feel relaxed and more confident about the future.”
Categories
- Articles (36)
- Consultants' blog (38)
- Events (2)
- News (58)
- Patient Information (19)
- Patients' viewpoint (71)
- Webcasts (4)
Tags
- Ahmed El-Modir (6)
- Alan Doherty (70)
- Aquablation (1)
- Artificial Urinary Sphincter (1)
- Benign Prostatic Hyperplasia (21)
- Biopsy (7)
- Bladder (8)
- Bladder Cancer (1)
- Bladder Pain (3)
- Brachytherapy (4)
- Cyberknife (7)
- Cystectomy (1)
- Dan Ford (3)
- Diet (1)
- Endometriosis (1)
- Greenlight Laser (21)
- HIFU (5)
- Ian McCafferty (1)
- Incontinence (11)
- kidney stones (1)
- Laparoscopic Prostatectomy (11)
- Male Sling (3)
- Maya Harris (3)
- Mesh Slings (2)
- Mohammed Belal (7)
- MRI before Biopsy (2)
- oligometastatic prostate cancer (1)
- Paul Anderson (10)
- PCA (16)
- Penile/Urethral (6)
- Peyronie’s (1)
- Prostate (71)
- Prostate Cancer (75)
- Prostate Cancer Symptoms (11)
- Prostate Keyhole Surgery (11)
- Prostatectomy (26)
- Prostatitis (6)
- PSA (27)
- Radical Prostatectomy (11)
- Rezum (2)
- SABR (1)
- TURP (13)
- tvt (1)
- TVT Sling (2)
- TVT Slings (2)
- Urethral Stricture (2)
- Urolift (9)
- vaginal mesh (1)
- vaginal mesh implant (1)
- Vaginal Slings (1)
- Vasectomy (2)
- Vasectomy Pain (1)
Archives
- October 2019 (2)
- September 2019 (2)
- July 2019 (4)
- May 2019 (4)
- March 2019 (1)
- January 2019 (2)
- December 2018 (3)
- November 2018 (1)
- October 2018 (1)
- August 2018 (1)
- June 2018 (1)
- April 2018 (3)
- March 2018 (1)
- February 2018 (1)
- January 2018 (1)
- November 2017 (3)
- October 2017 (1)
- July 2017 (1)
- June 2017 (1)
- May 2017 (3)
- March 2017 (1)
- February 2017 (3)
- January 2017 (3)
- December 2016 (1)